Group 5A: HER2+ Breast & Pan-Cancers; Clinical Trials; Immunotherapy; Novel Targets & Therapies



Thursday, June 15
2:00 pm – 3:30 pm Eastern Time (US/New York)



Mentor: Katie Edick

Katie Edick has been living with metastatic breast cancer (MBC) since 2016.  She has been a pediatric occupational therapist for 21 years.

Katie has volunteered with Little Pink Houses of Hope leading yearly retreats for families going through breast cancer. She provides mentoring to other MBC patients through Imerman Angels. Katie is engaging more with patient advocacy through sharing her story on local news programs, senate hearing committees, and podcasts to help educate and advocate for legislation and research to support families going through a breast cancer diagnosis. Currently, she is the social media coordinator for the Michigan Breast Cancer Coalition. She sits on two different workgroup committees in Michigan’s Department of Health & Human Services for young women with breast cancer; the advisory committee and the metastatic breast cancer committee. She attended the NBCC Advocate Leadership Summit and engaged with local legislators during that campaign, and has attended the annual Metastatic Breast Cancer Research Conference for three years. Check out her blog at terminallyjoyful.com.

Twitter: @KatieEdick

Scientist: Véronique Debien, M.D.

Véronique Debien was trained as a medical oncologist in France, after moving to clinical research at Institut Jules Bordet, Brussels, Belgium. Involved in academia-promoted clinical trials, the patients’ input provided helpful suggestions for the clinical trial setting. Additionally, passionate about early phases, her goal is to make cancer knowledge accessible to a larger panel of patients, demystify clinical research in oncology and thus optimize clinician-patient collaboration.

Twitter: @veroniquedebien